首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer
【2h】

Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer

机译:光电实时细胞分选仪用于在癌症小鼠模型中进行纵向CTC研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Circulating tumor cells (CTCs) play a fundamental role in cancer progression. However, in mice, limited blood volume and the rarity of CTCs in the bloodstream preclude longitudinal, in-depth studies of these cells using existing liquid biopsy techniques. Here, we present an optofluidic system that continuously collects fluorescently labeled CTCs from a genetically engineered mouse model (GEMM) for several hours per day over multiple days or weeks. The system is based on a microfluidic cell sorting chip connected serially to an unanesthetized mouse via an implanted arteriovenous shunt. Pneumatically controlled microfluidic valves capture CTCs as they flow through the device, and CTC-depleted blood is returned back to the mouse via the shunt. To demonstrate the utility of our system, we profile CTCs isolated longitudinally from animals over 4 days of treatment with the BET inhibitor JQ1 using single-cell RNA sequencing (scRNA-Seq) and show that our approach eliminates potential biases driven by intermouse heterogeneity that can occur when CTCs are collected across different mice. The CTC isolation and sorting technology presented here provides a research tool to help reveal details of how CTCs evolve over time, allowing studies to credential changes in CTCs as biomarkers of drug response and facilitating future studies to understand the role of CTCs in metastasis.
机译:循环肿瘤细胞(CTC)在癌症进展中起着基本作用。然而,在小鼠中,有限的血容量和血液中四氯化碳的稀少性妨碍了使用现有的液体活检技术对这些细胞进行纵向,深入的研究。在这里,我们介绍了一种光流体系统,可以在数天或数周的时间内每天从基因工程小鼠模型(GEMM)连续收集荧光标记的四氯化碳,持续数小时。该系统基于微流体细胞分选芯片,该芯片通过植入的动静脉分流器串行连接至未麻醉的小鼠。气动控制的微流阀在流经设备的过程中捕获CTC,消耗完CTC的血液通过分流器返回给小鼠。为了证明我们系统的实用性,我们对使用单细胞RNA测序(scRNA-Seq)的BET抑制剂JQ1治疗4天后从动物体内纵向分离的CTC进行了分析,并表明我们的方法消除了由小鼠异质性驱动的潜在偏见跨不同小鼠收集CTC时会发生这种情况。本文介绍的CTC分离和分选技术提供了一个研究工具,可帮助揭示CTCs随时间演变的细节,从而使研究CTCs的凭据变化成为药物反应的生物标记,并有助于未来的研究以了解CTCs在转移中的作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号